1-甲基-7-氮杂吲哚 | 27257-15-4

• 物质功能分类: 医药中间体 - 杂环化合物 - 吲哚类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯并吡啶类
• 中文名称: 1-甲基-7-氮杂吲哚
• 中文别名: 1-甲基-1H-吡咯[2,3-b]吡啶
• 英文名称: 1-methyl-1H-pyrrolo[2,3-b]pyridine
• 英文别名: N-methyl-7-azaindole；1-methyl-7-azaindole；N₁-Methyl-7-azaindole；1-methylpyrrolo[2,3-b]pyridine；N-methyl-1H-pyrrolo[2,3-b]pyridine；1-methyl-7-aza-1H-indole；7-aza-1-methylindole
• CAS: 27257-15-4
• 化学式: C₈H₈N₂
• mdl: MFCD09743451
• 分子量: 132.165
• InChiKey: ZVOCBNCKNQJAFL-UHFFFAOYSA-N

物化性质

• 沸点：
  112-116 °C(Press: 21 Torr)
• 密度：
  1.107 g/cm3(Temp: 22 °C)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  17.8
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2933990090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  存储条件：2-8°C，干燥密封

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 1-Methyl-1h-pyrrolo[2,3-b]pyridine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 1-Methyl-1h-pyrrolo[2,3-b]pyridine
CAS number: 27257-15-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H8N2
Molecular weight: 132.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-甲基-7-氮杂吲哚 在 1,1'-双(二苯基膦)二茂铁 、 palladium diacetate 、 potassium hydroxide 作用下， 以 二氯甲烷 、 甲苯 为溶剂， 反应 12.0h， 生成 (1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)(morpholino)methanone
  参考文献：
  名称：

  使用氯仿作为一氧化碳源，对钯取代的7-氮杂吲哚和其他杂芳烃进行钯催化的氨基羰基化

  摘要：

  已经开发了使用CHCl 3作为羰基源的钯催化的卤代7-氮杂吲哚的钯催化的氨基羰基化反应，用于酰胺官能团的直接引入。该协议扩展到其他杂芳烃，如吡唑并吡啶和吲唑。报道了关于杂芳烃和胺组分的反应的底物范围。该方法为药学上重要的杂环的氨基羰基化提供了另一种途径。

  DOI：

  10.1039/c7cc04339b
• 作为产物：
  描述：

  7-氮杂吲哚 在 potassium hydroxide 作用下， 以 二甲基亚砜 为溶剂， 生成 1-甲基-7-氮杂吲哚
  参考文献：
  名称：

  Copper-promoted decarboxylative direct C3-acylation of N-substituted indoles with α-oxocarboxylic acids

  摘要：

  开发了一种新型高效的铜促进脱羧直接C3酰基化反应，以α-氧代羧酸作为酰基源，用于N-取代吲哚合成3-酰基吲哚。

  DOI：

  10.1039/c3cc40389k
• 作为试剂：
  描述：

  、 甲基三氟硼酸钾 在 silver hexafluoroantimonate 、 1-甲基-7-氮杂吲哚 作用下， 反应 0.33h， 以33%的产率得到1-(o-tolyl)-1H-pyrrolo[2,3-b]pyridine
  参考文献：
  名称：

  机械化学无溶剂催化CH甲基化

  摘要：

  报道了（杂）芳烃的机械化学、无溶剂、高度区域选择性、铑催化的 C−H 甲基化。该反应表现出优异的官能团相容性，并被证明适用于生物活性化合物的后期 C−H 甲基化。该方法不需要外部加热，并且反应时间比之前基于溶液的 CH 甲基化方案要短得多。此外，机械化学方法被证明可以有效合成传统方法难以生成的有机金属配合物。

  DOI：

  10.1002/anie.202010202

文献信息

• Base-Promoted Three-Component One-Pot Synthesis of 3- (Thiomethyl)indoles with Paraformaldehyde under Aqueous Conditions
  作者：Fuhong Xiao、Guo-Jun Deng、Shanshan Yuan、Huawen Huang

  DOI：10.1055/s-0037-1611023

  日期：2018.12

  An ethylenediamine-promoted three-component synthesis of 3-(thiomethyl)indoles from indoles, thiophenols, and paraformaldehyde has been developed. Water is used as the green solvent in a simple and environmentally friendly procedure. Stable and low-toxicity paraformaldehyde is used as a carbon source.

  乙二胺促进了由吲哚、苯硫酚和多聚甲醛合成 3-（硫甲基）吲哚的三组分合成方法。水被用作绿色溶剂，程序简单且环保。使用稳定且低毒的多聚甲醛作为碳源。
• SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME
  申请人：BlinkBio, Inc.

  公开号：US20170202970A1

  公开（公告）日：2017-07-20

  Described herein are silicon based conjugates capable of delivering one or more payload moieties to a target cell or tissue. Contemplated conjugates may include a silicon-heteroatom core, one or more optional catalytic moieties, a targeting moiety that permits accumulation of the conjugate within a target cell or tissue, one or more payload moieties (e.g., a therapeutic agent or imaging agent), and two or more non-interfering moieties covalently bound to the silicon-heteroatom core.

  本文描述了基于硅的共轭物，能够将一个或多个有效载荷基团传递到靶细胞或组织。考虑到的共轭物可能包括一个硅-杂原子核心，一个或多个可选的催化基团，一个定位基团，允许共轭物在靶细胞或组织内积累，一个或多个有效载荷基团（例如，治疗剂或成像剂），以及与硅-杂原子核心共价结合的两个或更多个不干扰基团。
• Electrochemically Enabled C3-Formylation and -Acylation of Indoles with Aldehydes
  作者：Liquan Yang、Zhaoran Liu、Yujun Li、Ning Lei、Yanling Shen、Ke Zheng

  DOI：10.1021/acs.orglett.9b02433

  日期：2019.10.4

  Reported herein is an effective strategy for oxidative cross-coupling of indoles with various aldehydes. The strategy is based on a two-step transformation via a well-known Mannich-type reaction and a C–N bond cleavage for carbonyl introduction. The key step—the C–N bond cleavage of the Mannich product—was enabled by electrochemistry. This strategy (with over 40 examples) ensures excellent functional-group

  本文报道的是吲哚与各种醛的氧化交叉偶联的有效策略。该策略基于两步转化，通过众所周知的曼尼希型反应和羰基引入的C–N键裂解实现。关键步骤是曼尼希产品的C–N键断裂—是通过电化学实现的。这种策略（包含40多个示例）可确保出色的官能团耐受性以及药物分子的后期功能化。
• A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines, and Pharmaceuticals
  作者：J. Luke Koniarczyk、David Hesk、Alix Overgard、Ian W. Davies、Andrew McNally

  DOI：10.1021/jacs.7b11710

  日期：2018.2.14

  molecules are valuable for medicinal chemistry. The prevalence of pyridines and diazines in pharmaceuticals means that new ways to label these heterocycles will present opportunities in drug design and facilitate absorption, distribution, metabolism, and excretion (ADME) studies. A broadly applicable protocol is presented wherein pyridines, diazines, and pharmaceuticals are converted into heterocyclic phosphonium

  将氘和氚原子结合到有机分子中的方法对于药物化学很有价值。药物中吡啶和二嗪的流行意味着标记这些杂环的新方法将为药物设计提供机会，并促进吸收、分布、代谢和排泄 (ADME) 研究。提出了一个广泛适用的协议，其中吡啶、二嗪和药物被转化为杂环鏻盐，然后进行同位素标记。同位素以高产率掺入，并且通常具有独特的区域选择性。
• [EN] TOPICAL FORMULATIONS<br/>[FR] FORMULATIONS TOPIQUES
  申请人：NFLECTION THERAPEUTICS INC

  公开号：WO2020106304A1

  公开（公告）日：2020-05-28

  Provided herein are gelled topical formulations for the treatment of skin diseases comprising: a) a MEK inhibitor; b) one or more organic solvents in an amount of about 70% to about 99% by weight; and c) a gelling agent; wherein the one or more organic solvents are selected from the group consisting of C2-6 alcohol, a C2-6 alkylene glycol, a di-(C2-6 alkylene) glycol, a polyethylene glycol, C1-3 alkyl-(OCH2CH2)1-5-OH, DMSO, ethyl acetate, acetone, N-methyl pyrrolidone, benzyl alcohol, glycerin, and an oil; the gelling agent is hydroxypropyl cellulose having a molecular weight ranging from about 40,000 Dato about 2,500,000 Da; and wherein the gelled topical formulation has a viscosity of from 1 to 25,000 cps; and DMSO, when present, is combined with at least one other of said organic solvents such that DMSO is present in an amount of less than 50% by weight.

  本文提供了用于治疗皮肤疾病的凝胶局部制剂，包括：a) MEK抑制剂；b) 一种或多种有机溶剂，其重量约为70%至99%；和c) 凝胶剂；其中所述一种或多种有机溶剂选自以下组：C2-6醇，C2-6烷基二醇，二-(C2-6烷基)二醇，聚乙二醇，C1-3烷基-(OCH2CH2)1-5-OH，二甲基亚砜，乙酸乙酯，丙酮，N-甲基吡咯烷酮，苯甲醇，甘油和一种油；所述凝胶剂为分子量范围约为40,000 Da至2,500,000 Da的羟丙基纤维素；其中所述凝胶局部制剂的粘度为1至25,000 cps；当存在DMSO时，将DMSO与至少一种其他所述有机溶剂结合，使DMSO的重量不超过50%。